申请人:Asahi Kasei Pharma Corporation
公开号:EP2292592A1
公开(公告)日:2011-03-09
The sulfoneamide compounds having the following Formula (1), which can be used as an effective component of a CaSR antagonizing agent useful for prophylaxis and/or treatment of bone disorders including osteoporosis and etc., are provided. The compounds have an excellent activity of promoting PTH secretion. In addition, the compounds are useful as an effective component of a medicament for the prophylaxis and/or treatment of bone disorders such as osteoporosis, bone fracture, hypoparathyroidism and the like.
本发明提供了具有下式(1)的砜酰胺化合物,可用作预防和/或治疗骨质疏松症等骨病的 CaSR 拮抗剂的有效成分。这些化合物具有良好的促进 PTH 分泌的活性。此外,这些化合物还可作为预防和/或治疗骨质疏松症、骨折、甲状旁腺功能减退症等骨病的药物的有效成分。